• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Lilly wins NICE endorsement for tirzepatide in obesity—with a catch

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 04, 2024 at 11:42: AM
via A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has returned with an endorsement in obesity.

article source
 




Top Bottom
Back
Quote